For heart health, every moment counts.

Introducing the CorVista System®

Meet the world's first point-of-care system for evaluating the presence of significant coronary artery disease (CAD) and pulmonary hypertension (PH) in a single visit.
Learn more

Positive PH Population

Patient’s PH Score is Higher than 52%
of Elevated mPAP Subjects in Validation Population

Get Results for Your Patients Right Away

Industry leading accuracy to identify the right care for your patients.
For serious conditions like pulmonary hypertension (PH), the CorVista System’s breakthrough designated technology can reduce the time that patients spend searching for a correct diagnosis (often up to 2.5 years for certain forms of PH) and move them towards an appropriate care pathway.
Learn More

Answers In A Heartbeat

Deliver actionable results at the point of care.
Early diagnosis and intervention is key for patients struggling with cardiovascular disease.

That's why providers are turning to the CorVista System, a non-invasive, point-of-care cardiac diagnostic system powered by machine learning, to support accurate diagnosis of both CAD and PH. Equip your team and your patients with proven results at the point of care.
Learn More

CAD Positive Population

CAD Score
Patient’s CAD Score is Higher than 64% of CAD
Positive Subjects in Validation Population

Redefining The Standard Of Cardiac Care

We’re not just producing accurate results. We’re transforming the way
providers diagnose both CAD and PH.
Best-in-class time to result
Access critical cardiac data during patient encounters without the need for follow-up appointments or specialist referrals.
Proven accuracy
Rely on results from a machine learning system developed with more than 10,000 patients nationwide.
Optimized patient experience
Get results at the point of care with real-time data, allowing you to match the right patient to the right treatment at the right time, with no loss to follow-up.

Challenging the Status Quo

Join us in our goal to push for more impactful, equitable cardiac care for all.
The Status Quo
The CorVista Impact
Cardiovascular conditions present with similar symptoms
CorVista helps distinguish between conditions with overlapping symptoms.
Test results can take weeks to lead to unnecessary delays
CorVista test results are available at the point of care, to support earlier detection and intervention with no loss to follow-up.
Up to 50% of patients won't get follow-up testing due to delays, travel time, or a lack of information.
CorVista provides actionable information all from a non-invasive procedure.
Many cardiac tests are highly invasive and require specialized training for staff.
CorVista is a point-of-care solution that doesn't require specialist training.
There have been very few advancements in cardiac diagnostics in the past two decades.
CorVista uses advanced machine learning for accurate diagnosis of cardiac disease.
* The CorVista System is FDA cleared to detect coronary artery disease (CAD). Once approved, our system will have the ability to detect other cardiac conditions such as Left Ventricular Filling Pressure and Pulmonary Hypertension.

Learn More About the CorVista System

Explore the System

Learn how you can generate valuable insights into your patients’ cardiac health rapidly, accurately, and non-invasively at the point of care.
Learn More

CorVista For Physicians

See how the CorVista System is transforming the way physicians are diagnosing and treating coronary artery disease (CAD) and pulmonary hypertension (PH).
Learn More

CorVista For Patients

Find out how the CorVista System helps patients get heart health information faster and more easily during their doctor visits.
Learn More

Learn More About the CorVista System

Here's what physicians are saying about the CorVista System.
The CorVista System® with CAD Add-on and PH Add-on have been cleared to market as 510(k) devices. Please contact [email protected] for more information.

CAUTION - Additional CorVista System Add-on for Left Ventricular Filling Pressure is currently an investigational device limited by United States law to investigational use and is not available for commercial distribution.

CorVista® System is developed and manufactured by Analytics For Life, Inc., and licensed exclusively to CorVista Health.
CorVista provides actionable cardiac diagnostics at the point of care by applying advanced machine learning for more rapid and accurate diagnosis of cardiac disease.
Find Us
United States
3 Bethesda Metro Center,
Suite 700
Bethesda, MD 20814
(833) 267-8478
CorVista Health 2024 | All rights reserved
Privacy PolicyTerms of Use